Camber Spine Technologies announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion (ALIF) device, occuring in a 2-level lumbar procedure. ENZA features integrated fixation designed to promote minimally invasive fusion.
ENZA, which received FDA 510(k) clearance in mid-2Q16, is indicated for use with autogenous bone graft and may be implanted via laparascopic or an open anterior approach.
Camber Spine Technologies announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion (ALIF) device, occuring in a 2-level lumbar procedure. ENZA features integrated fixation designed to promote minimally invasive fusion.
ENZA, which received FDA...
Camber Spine Technologies announced the first implantation of the ENZA™ MIS Zero-Profile anterior lumbar interbody fusion (ALIF) device, occuring in a 2-level lumbar procedure. ENZA features integrated fixation designed to promote minimally invasive fusion.
ENZA, which received FDA 510(k) clearance in mid-2Q16, is indicated for use with autogenous bone graft and may be implanted via laparascopic or an open anterior approach.
Copy to clipboard 
